Evidence for a significant role of α3-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines

被引:199
作者
Dias, R [1 ]
Sheppard, WFA [1 ]
Fradley, RL [1 ]
Garrett, EM [1 ]
Stanley, JL [1 ]
Tye, SJ [1 ]
Goodacre, S [1 ]
Lincoln, RJ [1 ]
Cook, SM [1 ]
Conley, R [1 ]
Hallett, D [1 ]
Humphries, AC [1 ]
Thompson, SA [1 ]
Wafford, KA [1 ]
Street, LJ [1 ]
Castro, JL [1 ]
Whiting, PJ [1 ]
Rosahl, TW [1 ]
Atack, JR [1 ]
McKernan, RM [1 ]
Dawson, GR [1 ]
Reynolds, DS [1 ]
机构
[1] Merck Sharp & Dohme Res Labs, Neurosci Res Ctr, Harlow CM20 2QR, Essex, England
关键词
GABA(A); benzodiazepine; anxiety; alpha; 3; subunit; agonist; stress-induced hyperthermia;
D O I
10.1523/JNEUROSCI.1166-05.2005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The GABA(A) receptor subtypes responsible for the anxiolytic effects of nonselective benzodiazepines (BZs) such as chlordiazepoxide (CDP) and diazepam remain controversial. Hence, molecular genetic data suggest that alpha 2-rather than alpha 3-containing GABAA receptors are responsible for the anxiolytic effects of diazepam, whereas the anxiogenic effects of an alpha 3-selective inverse agonist suggest that an agonist selective for this subtype should be anxiolytic. We have extended this latter pharmacological approach to identify a compound, 4,2'- difluoro-5'-[8-fluoro-7-(1-hydroxy-1-methylethyl)imidazo[1,2-a]pyridin-3-yl] biphenyl-2-carbonitrile (TP003), that is an alpha 3 subtype selective agonist that produced a robust anxiolytic-like effect in both rodent and non-human primate behavioral models of anxiety. Moreover, in mice containing a point mutation that renders alpha 2-containing receptors BZ insensitive (alpha 2H101R mice), TP003 as well as the nonselective agonist CDP retained efficacy in a stress-induced hyperthermia model. Together, these data show that potentiation of alpha 3-containing GABAA receptors is sufficient to produce the anxiolytic effects of BZs and that alpha 2 potentiation may not be necessary.
引用
收藏
页码:10682 / 10688
页数:7
相关论文
共 33 条
[1]   The benzodiazepine binding site of GABAA receptors as a target for the development of novel anxiolytics [J].
Atack, JR .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2005, 14 (05) :601-618
[2]   Anxiogenic properties of an inverse agonist selective for α3 subunit-containing GABAA receptors [J].
Atack, JR ;
Hutson, PH ;
Collinson, N ;
Marshall, G ;
Bentley, G ;
Moyes, C ;
Cook, SM ;
Collins, I ;
Wafford, K ;
McKernan, RM ;
Dawson, GR .
BRITISH JOURNAL OF PHARMACOLOGY, 2005, 144 (03) :357-366
[3]   Regional differences in the inhibition of mouse in vivo [3H]Ro 15-1788 binding reflect selectivity for α1 versus α2 and α3 subunit-containing GABAA receptors [J].
Atack, JR ;
Smith, AJ ;
Emms, F ;
McKernan, RM .
NEUROPSYCHOPHARMACOLOGY, 1999, 20 (03) :255-262
[4]   Pharmacological characterization of a novel cell line expressing human α4β3δ GABAA receptors [J].
Brown, N ;
Kerby, J ;
Bonnert, TP ;
Whiting, PJ ;
Wafford, KA .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 136 (07) :965-974
[5]  
Collinson N, 2002, J NEUROSCI, V22, P5572
[6]   Anxiolytic-like action of diazepam:: mediated by GABAA receptors containing the α2 subunit -: Response from Crestani et al [J].
Crestani, F ;
Möhler, H ;
Rudolph, U .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2001, 22 (08) :403-403
[7]   Trace fear conditioning involves hippocampal α5 GABAA receptors [J].
Crestani, F ;
Keist, R ;
Fritschy, JM ;
Benke, D ;
Vogt, K ;
Prut, L ;
Blüthmann, H ;
Möhler, H ;
Rudolph, U .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (13) :8980-8985
[8]  
Davis M., 2000, The Amygdala, V2, P213, DOI 10.1146/annurev.ne.15.030192.002033
[9]  
FACKLAM M, 1992, J PHARMACOL EXP THER, V261, P1113
[10]   The neuroanatomical and neurochemical basis of conditioned fear [J].
Fendt, M ;
Fanselow, MS .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1999, 23 (05) :743-760